Heptavalent recombinant human papillomavirus vaccine (6,11,16,18,52,58, Chengdu institute of biological products)
六价重组人乳头瘤病毒疫苗（6,11,16,18,52,58型， 成都生物制品）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHeptavalent recombinant human papillomavirus vaccine (6,11,16,18,52,58, Chengdu institute of biological products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesChengdu Institute Of Biological Products Co LtdBeijing Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesChengdu Institute Of Biological Products Co LtdBeijing Institute Of Biological Products Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A